value-based pricing
ABPI outlines vision for drug pricing reform
August 3, 2012Sales and Marketing ABPI, NICE, PPRS, VBP, Whitehead, value-based pricing
The ABPI has set out what it wants to see from the new drug pricing system in the UK. Negotiations …
Value-based pricing won’t encourage innovation, says ABPI
September 23, 2011Sales and Marketing value-based pricing
The ABPI has come out against the government’s reforms of drug pricing in the UK, saying its plans need a …
Government seeks to salvage pharma pricing reforms
July 19, 2011Sales and Marketing NICE, value-based pricing
The government is pushing ahead with plans to introduce value-based pricing in 2014, despite acknowledging the new system still requires …
UK pricing reform derailed
July 15, 2011Sales and Marketing NICE, PPRS, value-based pricing
Plans to revolutionise the pricing of medicines in the UK look to be another casualty in the Department of Health’s …
NICE gains expanded role alongside value-based pricing
June 21, 2011Sales and Marketing NHS reforms, NICE, value-based pricing
NICE will be given a wider remit to oversee social care and its guidance used alongside value-based pricing as part …
NICE reprieved by government U-turn
June 20, 2011Sales and Marketing Health and Social Care Bill, NICE, value-based pricing
The government has performed an unexpected U-turn by allowing NICE to retain its powers to decide which new drugs the …
VBP: a fait accompli or room for manoeuvre?
April 18, 2011Sales and Marketing value-based pricing
The pharma industry is seeking a compromise on the UK’s proposed value- based pricing, which promises to revolutionise the country’s …
Doubts cast on new Cancer Drugs Fund
April 1, 2011Cancer Drugs Fund, value-based pricing
There are stark regional variations in the number of doctors using the government’s provisional Cancer Drugs Fund, according to a …
NHS Confederation: value-based pricing could increase NHS costs
March 18, 2011Sales and Marketing NHS Confederation, PPRS, Pharmaceutical Price Regulation Scheme, UK drug pricing, VBP, value-based pricing
Government plans to introduce value-based pricing in the UK could increase the NHS drugs bill without improving the effectiveness of …
Pharma industry wary of UK drug pricing changes
March 17, 2011Sales and Marketing ABPI, National Voices, PPRS, Pharmaceutical Price Regulation Scheme, Simon Jose, UK drug pricing, VBP, value-based pricing
The ABPI wants the current drug pricing system to remain, but has welcomed government proposals to take a broader view …
Value-based pricing will not harm industry, says NICE chief
February 18, 2011Sales and Marketing Health Select Committee, Health and Social Care Bill, NHS reform, NICE, Sir Andrew Dillon, value-based pricing
NICE’s chief executive Sir Andrew Dillon says he believes plans to introduce value-based pricing of medicines will not have a …
Lilly chief issues warning on UK reforms
February 11, 2011Research and Development, Sales and Marketing John Lechleiter, US health reforms, healthcare reform, lilly, patent box, value-based pricing
Lilly chief executive John Lechleiter has warned that two key UK initiatives could fall seriously short of encouraging investment in …
Cancer Drugs Fund must not be forerunner to value-based pricing – EMIG
January 19, 2011Sales and Marketing Cancer Drugs Fund, EMIG, Ethical Medicines Industry Group, NHS, value-based pricing
The association representing small to medium UK pharma companies says the forthcoming Cancer Drugs Fund is welcome – but must …
Liberating the NHS … whether it likes it or not
December 22, 2010Sales and Marketing GP consortia, NHS, NHS board, NHS reforms, value-based pricing
When health secretary Andrew Lansley announced plans in July to abolish the management structure of England’s health service, and hand …
Government consults on UK value-based pricing
December 17, 2010Sales and Marketing ABPI, Drug pricing, pharma pricing, value-based pricing
The government has begun a consolutation process for its plans to change the way medicines are priced in the UK. …
